Not Yet RecruitingNot Applicable

Effect of Neuromuscular Electrical Stimulation on Muscle Mass in ECMO Patients

Egypt50 participantsStarted 2026-05

Plain-language summary

The goal of this clinical trial study: is to determine the effectiveness of neuromuscular electrical stimulation in critically ill patients undergoing extracorporeal membrane oxygenation. The main questions it aims to answer are: * Does NMES has an effect when added to conventional protocol for ECMO patients? * Does NMES will help in preserve muscle mass? * Patients will recieve the treatment untill discharge. * Assesment will be done before and after treatement

Who can participate

Age range20 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult patients of both sexes aged 20 to 50 years * Patients receiving extracorporeal membrane oxygenation (ECMO) (veno-venous or veno- arterial) * Patients admitted to the ECMO unit for at least 72 hours * Hemodynamically stable patients as determined by the treating medical team * Patients medically eligible for participation in physiotherapy and neuromuscular electrical stimulation (NMES) Exclusion Criteria: * Hemodynamic instability * Patients requiring ECMO support for less than 72 hours * Unstable cardiac arrhythmias * Hemorrhagic shock * Deep venous thrombosis or pulmonary embolism * Lower limb open wounds or acute skin burns at electrode placement sites * Pregnant patients * Patients receiving intra-aortic balloon pump (IABP) support * Any contraindication to NMES application

What they're measuring

Change in quadriceps muscle mass

Timeframe: Baseline and after 7 days of intervention

Trial details

NCT IDNCT07566702

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-08

Contact for this trial

Ehssan R Mahmoud, Master

1096403137 ehssan.rabie.98@gmail.com